Angitia Biopharma snags $46m and 48 more Greater China deals worth $1b

Angitia Biopharma snags $46m and 48 more Greater China deals worth $1b

25 October, 2023

Edited by: Padma Priya

3H Health Investment Elikon Venture OrbiMed Healthcare Fund Management

Printed by Unregistered user on Mon, 28 Jul 2025 10:31:41 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's Detong Capital raises just over $200m for new RMB fund, eyes $274m final close

Three listed Chinese firms used endangered animal parts as ingredients: Report

Read more from Greater China

Chinese AI firms form partnerships to build local ecosystem amid US curbs

Multinationals rush to snap up Chinese biotech assets amid drug licensing boom